Latest Market Study on RWE Oncology Market Size with Historical and Forecast Data | Industry Growth Report: Forecast, 2023-2030

The global RWE oncology market is expected to approach US$ 1,715 million by 2030, with an annual growth rate of more than 13.2%, market report by RationalStat

Wilmington, Delaware, Sept. 15, 2023 (GLOBE NEWSWIRE) —

Competition Analysis and Market Structure

These players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global RWE oncology market include,

• In October 2022, Ontada, a McKesson real-world evidence (RWE) company, and BeiGene, a biotech, have formed a new alliance. The collaboration will leverage Ontada’s RWE experience to help BeiGene meet its objective of delivering ten medications to clinics each year. The two companies will also collaborate to strengthen the use of RWE in cancer regulatory decision-making.
• In September 2022, According to Verantos, a leader in high-validity real-world evidence (RWE), the Verantos Evidence Platform has officially debuted. Life sciences companies can use the Verantos Evidence Platform to create RWE that meets the highest evidentiary standards, including those stated in Food and Drug Administration (FDA) drafting guidance.

Some of the prominent players and suppliers operating and contributing significantly to the global RWE oncology market growth include IQVIA Holdings Inc., ICON plc, PPD, Inc., SYNEOS HEALTH, INC., CLARIVATE PLC, Medpace Holdings Inc., Symphony Innovation, LLC, Clinigen Group plc, Cognizant Technology Solutions Corporation, Oracle Corporation, PAREXEL International Corporation, PerkinElmer, Inc., SAS Institute Inc., UnitedHealth Group Incorporated, and Flatiron Health, among others.

Get A Free Sample- https://store.rationalstat.com/store/global-rwe-oncology-market/#tab-ux_global_tab

RationalStat has segmented the global RWE oncology market based on component, application, end user and region

• Global RWE Oncology Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Component
  • Real-world Datasets
    • Disparate Datasets
      • EMR/HER/Clinical Data
      • Claims & Billing Data
      • Pharmacy Data
      • Cancer Registries
      • Other Disparate Datasets
    • Integrated Datasets
  • Real-world Consulting & Analytics Services
• Global RWE Oncology Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Application
  • Drug Development & Approvals
  • Market Access & Reimbursement/Coverage Decisions
  • Post-market Surveillance
  • Medical Device Development & Approvals
  • Other applications
• Global RWE Oncology Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by End User
  • Pharmaceuticals
  • Biotechnology Industries
  • Healthcare Service Providers
• Global RWE Oncology Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Region
  • North America RWE Oncology Market
    • US
    • Canada
  • Latin America RWE Oncology Market
    • Brazil
    • Mexico
    • Rest of Latin America
  • Western Europe RWE Oncology Market
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Benelux
    • Nordic
    • Rest of Western Europe
  • Eastern Europe RWE Oncology Market
    • Russia
    • Poland
    • Hungary
    • Other CIS Countries
    • Rest of Eastern Europe
  • Asia Pacific RWE Oncology Market
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • ASEAN
      • Indonesia
      • Thailand
      • Philippines
      • Vietnam
      • Malaysia
      • Rest of ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa RWE Oncology Market
    • GCC
      • Saudi Arabia (KSA)
      • United Arab Emirates (UAE)
      • Rest of the GCC
    • South Africa
    • Nigeria
    • Turkey
    • Rest of the Middle East & Africa

For more information about this report- https://store.rationalstat.com/store/global-rwe-oncology-market

Key Questions Answered in the RWE Oncology Report:

• What will be the market value of the global RWE oncology market by 2030?
• What is the market size of the global RWE oncology market?
• What are the market drivers of the global RWE oncology market?
• What are the key trends in the global RWE oncology market?
• Which is the leading region in the global RWE oncology market?
• What are the major companies operating in the global RWE oncology market?
• What are the market shares by key segments in the global RWE oncology market?  

Explore Our Trending Reports

• Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market– Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market is expected to grow at a CAGR 8.2% over the forecast period of 2022-2028.
• Global Ranitidine Market– Global Ranitidine Market is expected to grow at a CAGR of 1.8% over the forecast period of 2022-2028
• Global Probiotics Supplements Market– Global Probiotics Supplements Market is expected to grow at a CAGR of 14.1% over the forecast period of 2022-2028
• Global Plastic Surgery Scaffold Market– Global Plastic Surgery Scaffold Market is expected to grow at a significant CAGR over the forecast period of 2022-2028
• Global Placental Stem Cell Collection and Storage Market– Global Placental Stem Cell Collection and Storage Market is expected to grow at a CAGR of 22% over the forecast period of 2022-2028
• Global Pharmaceutical Yeast Powders Market– Global Pharmaceutical Yeast Powders Market is expected to grow at a significant CAGR over the forecast period of 2022-2028
• Global Immunosuppressants API Market– Global Immunosuppressants API Market is expected to grow at a CAGR of 8.2% over the forecast period of 2022-2028
• US Pharmacy Market– US pharmacy market is anticipated to attain a value of US$ 706 million by 2030, growing at a compound annual growth rate (CAGR) of 3.9% during the forecast period.
• Global Retinoblastoma Treatment Market– Global retinoblastoma treatment market is anticipated to attain a value of US$ 3.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.
• Global Pet Relaxants Market– Global pet relaxants market is anticipated to attain a value of US$ 443 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
• Global Atopic Dermatitis Market–Global atopic dermatitis market is anticipated to attain a value of US$ 19.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period.

Research Methodology

RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.

RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:

• Defining the problem by understanding the type of market and data required by the client.
• Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
• Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
• Evaluating and analyzing the data by referring to data sources utilized and leveraged.
• Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.

Download Key Insights and Market Data – Raise a Query

About RationalStat LLC                    

RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.

RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.

Contact

RationalStat LLC

Kimberly Shaw,

Content and Press Manager

[email protected]

US Phone: +1 302 803 5429

UK Phone:  +44 203-287-1245

LinkedIn | Facebook | Twitter | Instagram | Pinterest